TO: |
Deans, Directors, Department Chairpersons, and Department Administrators (for distribution to all Faculty) |
FROM: |
Kim Moreland, Director |
SUBJECT: |
Industry-Sponsored Clinical Trial Rate |
For well over ten years, industry-sponsored clinical trials at the University of Wisconsin have been considered an exception to the Federally negotiated F&A rate. Justification for the reduced rate includes several factors:
Effective July 1, 2006, the University of Wisconsin’s F&A rate for industry-sponsored clinical trials will be 28% of Total Direct Costs. The new rate should be applied to any proposals for new industry-sponsored clinical trials received in Research and Sponsored Programs on or after July 1, 2006. We do not plan to re-negotiate agreements for trials already in progress under signed agreements.
The principal reasons for this rate increase include:
Please note: The full Federal research rate will still apply to clinical trials funded by NIH. Industry-sponsored research, other than clinical trials, is also subject to the full Federally negotiated rate. The University’s current F&A rates can be found on the RSP website at http://www.rsp.wisc.edu/rates/index.html.
xc: School/College Research Administrators